Attendees will gain insight into:

How to apply a graded evidence framework to distinguish established protocol decisions from limited evidence and unresolved questions in paediatric obesity trials
How to evaluate BMI SDS, percentage BMIp95 and percentage change in BMI while interpreting DXA body composition in the context of bone accrual and puberty
How to assess exploratory biomarkers of metabolic dysfunction and determine their readiness for regulatory use
How family-level measures, age-appropriate PRO instruments, cross-cultural validation and engagement approaches can support retention and reduce visit burden
How to design a paediatric obesity programme that addresses FDA, EMA and NMPA requirements across multiple regions

Contact the host of Improve Paediatric Obesity Trials with Evidence-Based Design

There were 0 errors found in the information you submitted: